Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria

NCT00674596 is registered in ClinicalTrials.gov with Gulhane School of Medicine as lead sponsor.

NCT NCT00674596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00674596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria
Lead sponsor
Gulhane School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2006
Completion date
March 31, 2008
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, proteinuria, renin angiotensin system